appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Venus Remedies Ltd
VENUSREM
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Venus Remedies Limited is engaged in pharmaceutical product manufacturing business. The Company provides formulations and manufactures dosage injectables.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Notice Of Shareholders Meetings-XBRL
Outcome of Board Meeting
Venus Remedies Limited has informed the Exchange regarding Board meeting held on August 13, 2024.1. Unaudited Financial Results for the quarter ended on 30th June 2024 along with Limited review report.2. Appointed Mr. Jagdish Chander Sharma and Dr. Anil Kumar as additional Directors (Non-Executive Independent Director) of the company w.e.f. 13th August 2024 to hold office till the conclusion of next Annual General Meeting. The said appointment will be regularized for the period of 5 years subject to shareholders approval in next Annual General Meeting.3. The date of 35th Annual General Meeting as 23rd September 2024 at 11:30 a.m. (1ST) through Video Conferencing ("VC") I Other Audio-Visual Means ("OAVM").4. The books closure (Register of Members and Share Transfer Books) for the purpose of 35th Annual General Meeting will commence from 17th September 2024 to 23rd September 2024 (both days inclusive).5. The cut-off date for determining eligible shareholders for remote e-voting/ e- voting will be on September 16, 2024. Any person, who is a member of the company as on September 16, 2024, shall be entitled to vote through remote e-voting/ e- voting. The remote e-voting period commences on September 20, 2024 (9:00 a.m.) and ends on September 22, 2024 (5 :00 p.m.). | Download
Venus Remedies Limited has informed the Exchange regarding Board meeting held on August 13, 2024.1. Unaudited Financial Results for the quarter ended on 30th June 2024 along with Limited review report.2. Appointed Mr. Jagdish Chander Sharma and Dr. Anil Kumar as additional Directors (Non-Executive Independent Director) of the company w.e.f. 13th August 2024 to hold office till the conclusion of next Annual General Meeting. The said appointment will be regularized for the period of 5 years subject to shareholders approval in next Annual General Meeting.3. The date of 35th Annual General Meeting as 23rd September 2024 at 11:30 a.m. (1ST) through Video Conferencing ("VC") I Other Audio-Visual Means ("OAVM").4. The books closure (Register of Members and Share Transfer Books) for the purpose of 35th Annual General Meeting will commence from 17th September 2024 to 23rd September 2024 (both days inclusive).5. The cut-off date for determining eligible shareholders for remote e-voting/ e- voting will be on September 16, 2024. Any person, who is a member of the company as on September 16, 2024, shall be entitled to vote through remote e-voting/ e- voting. The remote e-voting period commences on September 20, 2024 (9:00 a.m.) and ends on September 22, 2024 (5 :00 p.m.). | Download
Cash Dividend
Final • Div/Share: ₹ 3
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant